Features
The Potential Impact of Home OCT on nAMD Management
This new imaging modality may help physicians identify optimal treatment intervals quickly and with greater confidence.
By Anat Loewenstein, MD, MHA, Mathew W. MacCumber, MD, PhD
Widefield OCTA: Advancing Retinal Imaging and Diagnostics
Expanded visualization of the peripheral retina is useful for diagnosing and managing many retinal diseases.
By Shivesh H. Shah, BA, Rajiv M. Sastry, BA, John B. Miller, MD
Clinical Advances of Intraoperative OCT in Vitreoretinal Surgery
Innovations in iOCT technology are shaping surgery in significant ways.
By Eric W. Lai, MD, Timothy S. Lee, MD, Sidney A. Schechet, MD
Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT
A conversation with Christina Y. Weng, MD, MBA
By Christina Y. Weng, MD, MBA, Jim Gallagher, senior managing editor
Web Exclusives
An Imaging-related Clinical Trial Endpoint
Ellipsoid zone integrity is an OCT biomarker in dry age-related macular degeneration that the FDA now supports as an approvable clinical trial endpoint.
By Jim Gallagher, senior managing editor
Supported Content
Ultra-Widefield Image of the Month
Multimodal UWF Imaging Quickly Reveals Proliferative Diabetic Retinopathy
Departments
Upfront: Why Retinal Physician Matters
By Diana V. Do, MD
Controversies in Care: The Evidence That Ang-2 Suppression Confers a Clinical Benefit
Is faricimab’s efficacy and extended durability due to its Ang-2 inhibiting properties, or simply the effect of a larger anti-VEGF dose?
By Michael Colucciello, MD, Arshad M. Khanani, MD, MA, FASRS, Jennifer I. Lim, MD, FARVO, FASRS
New Product Applications: Glasses Offer Vision Enhancement With a Virtual Assistant
Eyedaptic’s Eye6 wearable vision aid leverages AI to help patients with low vision perform daily tasks.
By Karen Appold, contributing writer
Coding Q&A: Proper Coding for Home OCT Scanning
A dedicated Category III CPT code allows retina practitioners to bill for reviewing, interpreting, and reporting data collected from home OCT every 30 days.
By Elizabeth Cifers, MBA, MSW, CHC, CPC
Clinical Trial Update January/February 2025
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.
News
Retinal Physician Welcomes Diana V. Do, MD, as New Editor in Chief
Dr. Do, vice chair of clinical affairs and professor of ophthalmology at the Byers Eye Institute, succeeds Peter K. Kaiser, MD, as editor in chief of the magazine.